Category:

The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, was authorized for use...the third issued by the U.S. Food and Drug Administration, will give health authorities a desperately needed new source of doses as they scramble to ramp up inoculations ahead of elusive emerging strains...J&J said it has begun shipping the vaccine to the U.S. government, which is managing allocation and distribution. That indicates first doses could be administered during the coming week...READ MORE

Nevada health officials are still awaiting answers about why the state has one of the nation’s lowest COVID-19 vaccine allocations from the federal government...As of this week, the state remained ranked among the bottom 10 states in terms of vaccine allocation per capita. It had received about 21,070 first doses per 100,000 adult residents...READ MORE

The uncertainty of coronavirus disease 2019 caused anticipatory purchasing of medications around the world, driving demand to an unprecedented high. Meanwhile, drug factories shut down in order to prevent the spread of COVID-19, the drug-supply chain was disrupted, and drug shortages resulted. In the face of these drug shortages, pharmacy personnel responded by initiating local policy changes, implementing detailed antibiotic stewardship, and enacting quantity limits for in-demand medications...READ MORE

Almost two-thirds of Americans now give the pharma industry a thumbs up. It’s a stunning reversal from just one year ago when only about one-third (32%) rated the industry positively, according to The Harris Poll surveys...In its most recent February poll, 62% rated the pharma industry as a 5, 6 or 7 on a 7-point scale, with 1 equating to “very bad” and 7 to “very good.” That’s an increase of 30 percentage points since January 2020, before the pandemic hit U.S. shores...And that's a key point: The hockey-stick upturn stems directly from pharma's proactive response to COVID-19...READ MORE

The Food and Drug Administration advisory committee endorsed Johnson & Johnson’s coronavirus vaccine late Friday afternoon...The vaccine appears widely effective against the virus and is especially good at preventing severe cases...And because the vaccine is given as a single dose and is easy to ship, it presents an appealing profile for public health officials struggling to vaccinate hard-to-reach or skeptical populations...READ MORE

It’s lights, camera, action for Pfizer and BioNTech vaccine scientists and executives. They're starring in “Mission Possible,” a branded content film from Pfizer and National Geographic that tracks the COVID-19 vaccine's journey to market...The movie-length product placement is a behind-the-scenes look at Comirnaty, the now-authorized coronavirus shot Pfizer developed and produced in concert with its partner BioNTech. Pfizer provided National Geographic's scientific storytellers “unprecedented access” to the vaccine's development...READ MORE

Health authorities in some European countries are facing resistance to AstraZeneca’s COVID-19 vaccine after side-effects led hospital staff and other front-line workers to call in sick, putting extra strain on already-stretched services...Such symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response. They usually fade within a day or so...But with the AstraZeneca shot the latest to be rolled out, health authorities in France have issued guidance to stagger giving the shot, two regions in Sweden paused vaccinations, and in Germany some essential workers are refusing it...READ MORE

Nevada on Thursday reported higher-than-average tallies of new coronavirus cases and additional fatalities over the preceding day...Updated figures from the Department of Health and Human Services posted to the state’s coronavirus website showed 571 new coronavirus cases and 14 additional deaths from Wednesday’s report. That brought cumulative totals for the state to 292,630 cases and 4,933 deaths...READ MORE

Pfizer has been accused of bullying governments in Latin America over coronavirus disease 2019 vaccine negotiations, a recent investigative article revealed...The accusations involve the company’s requests that some countries establish sovereign assets as a guarantee against the costs associated with future legal suits made on behalf of citizens who experience an adverse event after the shot...The story, published in The Bureau of Investigative Journalism, states that demands made by the global pharmaceutical giant Pfizer resulted in a three-month delay in a vaccine deal for one country. In the case of Argentina and Brazil, the countries made no national deals with the company...READ MORE

Rich countries are on course to have over a billion more doses of COVID-19 vaccines than they need, leaving poorer nations scrambling for leftover supplies as the world seeks to curb the coronavirus pandemic...In an analysis of current supply deals for COVID-19 vaccines, the ONE Campaign said wealthy countries, such as the United States and Britain, should share the excess doses to “supercharge” a fully global response to the pandemic...the United States, the European Union, Britain, Australia, Canada and Japan have already secured more than 3 billion doses - over a billion more than the 2.06 billion needed to give their entire populations two doses...READ MORE